Investigator Location Services, Inc. (ILS), the largest study broker with expanded access to 24,000+ experienced investigators, reports the operational results since the company’s launch in July 2001. 304 sponsor and CRO companies have used ILS to recruit over 7,160 + investigators for 685 protocols including difficult to place projects. ILS investigator recruiting services are usually free to sponsors and CROs as investigators pay ILS fees.

Today’s headline

The effect of the national and global economic downturn has impacted clinical research which is usually a recession proof industry.

Impact of current economic conditions on sponsors and CROs

Significant restructuring as a result of mergers, acquisitions and layoffs at sponsors and CROs has put pressure on clinical operations to do more with less and increase operational efficiency. ILS’s extensive work with 304 sponsors and CROs over the years has positioned ILS to react rapidly to urgent requests for help recruiting investigators.

Impact of current economic conditions on investigators

For investigators, cash flow has become more of a challenge than ever before with many current projects cancelled or put on hold and new projects delayed. ILS has seen a significant increase in the number of investigators previously resistant to the study broker model now registering to be in our database.

Expanded US and Canadian investigator capacity

As a result, ILS’s proprietary investigator database has grown to be the most comprehensive database of investigator capacity in the US and Canada. In addition, ILS now has access to investigators in Latin America including Argentina, Chile, Brazil, Columbia, Mexico and the Dominican Republic through partners.

ILS’s unique position

“Nine years of building relationships with sponsors, CROs and investigators has provided ILS with a unique opportunity to help all parties during these challenging times” said Joe Bollert, Ph.D., president of ILS. “Although there are signs of improvement, we expect the economic impact on clinical trials to last for some time and look forward to helping sponsors, CROs and investigators maximise their efficiencies.”

Comprehensive outreach

ILS has instant, expanded access to 24,000+ investigators which represents most of the experienced investigators in the US and covers all medical specialties.